tiprankstipranks
Trending News
More News >

Cigna’s Evernorth caps monthly weight loss drug cost at $200

Evernorth, the health services division of Cigna (CI), announced yesterday a pharmacy benefit offering that make weight loss medications Wegovy and Zepbound more available to patients. Through direct negotiations with the manufacturers, Evernorth has ensured that patients’ monthly cost will not exceed $200, the company said in a statement. Evernorth’s monthly copay for GLP-1 weight loss medicines will be limited to no more than $200, which will have the added benefit of counting towards the patient’s annual deductible, it added. Shares of Hims & Hers (HIMS) are down 10% to $52.12 following the news from Evernorth.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue